Methotrexate once-weekly for autoimmune diseases: new measures to reduce risk of fatal overdose due to inadvertent daily instead of weekly dosing

MHRA continues to receive reports of inadvertent overdose due to more frequent dosing (including daily administration). New measures have been implemented to prompt healthcare professionals to record day of week for intake and to remind patients of dosing and risks of overdose.

Medicines and Healthcare products Regulatory Agency